Valeant Pharma (NYSE: VRX) issued the following statement following earlier accusations of fraud by short seller Citron Research, which has ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE